Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
What's New at TheBody.com
  
  • Email Email
  • Glossary Glossary

 

Equivalent Efficacy With Lower Dose Darunavir

Polly Clayden, HIV i-Base; Posted Dec 17, 3:00 p.m. ET

A reduced dose of darunavir boosted with ritonavir was effective in two reports from Italy and Spain.

Philly's Transit System Sues Gilead for "Price-Gouging" Price of Hepatitis C Drug

Sue Saltmarsh, TheBody.com; Posted Dec 16, 2:29 p.m. ET

Noting that Gilead has recorded "an astounding $8.5 billion in Sovaldi sales," SEPTA says the pricing of Sovaldi cannot be defended by patent rights.

Efavirenz-Associated Gynaecomastia Reported in South Africa

Polly Clayden, HIV i-Base; Posted Dec 16, 2:21 p.m. ET

Efavirenz-associated gynaecomastia (benign proliferation of glanular breast tissue in males) has been frequently reported to the South African national HIV and TB healthcare workers hotline. Results from a study conducted to look at this phenomenon were presented at the 2014 Southern African Clinicians Society Conference.

Top 10 HIV Clinical Developments of 2014

David Wohl, M.D., TheBodyPRO.com; Posted Dec 15, 5:32 p.m. ET

A year can pass so quickly -- that's as true in the field of HIV science as it is anywhere else. Yet in its brief time on our calendars, 2014 brought a host of important events that may change the way we approach HIV prevention and treatment. David Wohl, M.D., summarizes 10 key highlights.

Share Your Stories!

Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.

Day One With HIV: Finding Out Your Status, in Your Own Words

Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?


Other Sides of HIV: People Taking HIV Meds Share Stories About Side Effects

Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?

 

Let Me Clear My Throat on White Men in Communities of Color

Aaron Laxton, TheBody.com; Posted Dec 15, 5:06 p.m. ET

In the middle of turbulent times, when we are trying to prove that #blacklivesmatter, how can white gay allies add to the conversation? And what does this conversation mean for those in the fight against HIV?

Zero HIV Infections Among PrEP Users With 45% Reporting Less Condom Usage

Warren Tong, TheBodyPRO.com; Posted Dec 15, 1:58 p.m. ET

Increased condomless sex was reported by 45% of 90 PrEP (pre-exposure prophylaxis) users who were part of an HIV care and prevention program. However, there were zero new HIV infections among the more than 500 total participants in the program.

Increased Risk of Treatment-Related Hepatotoxicity in HIV-Positive Pregnant Women

Polly Clayden, HIV i-Base; Posted Dec 15, 1:05 p.m. ET

Evidence from the U.K. and Ireland that pregnancy increases the risk of liver enzyme elevation among pregnant women on antiretroviral treatment was shown at the 2014 HIV Drug Therapy Glasgow Congress.

Recommendations for HIV Prevention With Adults and Adolescents With HIV in the United States, 2014

U.S. Centers for Disease Control and Prevention; Posted Dec 12, 9:39 a.m. ET

This updated guideline is a comprehensive compilation of new and longstanding federal recommendations about biomedical, behavioral, and structural interventions that can help reduce the risk of HIV transmission from persons with HIV by reducing their infectiousness and their risk of exposing others to HIV.

My Health Tracker

My Health Tracker

My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.

Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.

 

10 Under-the-Radar HIV Stories From 2014

Warren Tong, TheBody.com; Posted Dec 10, 10:09 p.m. ET

There were many developments in HIV this year: some big, some small. While not all HIV research is groundbreaking, many results are noteworthy. They didn't make many headlines, but here are 10 important stories about HIV this year that went under the radar.

Gender Differences in Use of Cardiovascular Disease-Related Interventions: D:A:D Study

Polly Clayden, HIV i-Base; Posted Dec 10, 4:31 p.m. ET

Use of most cardiovascular disease (CVD) interventions was lower among women than men in the D:A:D study, according to data presented at the 2014 HIV Drug Therapy Glasgow Congress.

Queerty Names the 10 Sexiest Gay Men Living With HIV

Mathew Rodriguez, TheBody.com; Posted Dec 9, 4:36 p.m. ET

Who are the top 10 sexiest gay men living with HIV? You won't be disappointed.

Lamivudine Inferior to Emtricitabine in Dutch Cohort but Interchangeable in Other Studies

Polly Clayden, HIV i-Base; Posted Dec 9, 1:32 p.m. ET

The Dutch national observational cohort found emtricitabine was associated with better virological response than lamivudine in a study presented at HIV Drug Therapy Glasgow Congress 2014.


>> Browse Older Featured Stories

 


  
  • Email Email
  • Glossary Glossary
Advertisement